English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1654]
News [6533]
Articles [101]
Editorials [4]
Conferences [186]
elearning [21]
Zoning in on specifics of Mediterranean diet for colorectal health
Zoning in on specifics of Mediterranean diet for colorectal health
Subtle molecular changes along the upper digestive tract could guide cancer therapy
Subtle molecular changes along the upper digestive tract could guide cancer therapy
Last Month in Oncology with Dr. Bishal Gyawali: June 2017
Last Month in Oncology with Dr. Bishal Gyawali: June 2017
Study shows biomarkers can predict which ER-positive breast cancer patients respond best to first-line therapy
Study shows biomarkers can predict which ER-positive breast cancer patients respond best to first-line therapy
Using 'sticky' nanoparticles, researchers develop strategy to boost body's cancer defenses
Using 'sticky' nanoparticles, researchers develop strategy to boost body's cancer defenses
Axicabtagene ciloleucel for refractory aggressive non-Hodgkin lymphoma
Axicabtagene ciloleucel for refractory aggressive non-Hodgkin lymphoma
Bleeding or clotting in elderly patients with cancer-associated venous thromboembolism: which is worse?
Bleeding or clotting in elderly patients with cancer-associated venous thromboembolism: which is worse?
CTL019 in adult patients with relapsed or refractory diffuse large B-cell Lymphoma
CTL019 in adult patients with relapsed or refractory diffuse large B-cell Lymphoma
Existing drugs could benefit patients with bone cancer, genetic study suggests
Existing drugs could benefit patients with bone cancer, genetic study suggests
Cerdulatinib demonstrates rapid tumour responses in a phase 2 study for relapsed/refractory NHL
Cerdulatinib demonstrates rapid tumour responses in a phase 2 study for relapsed/refractory NHL
<1...412413414415416...654>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top